FDA panel recommends Pfizer’s low-dose COVID vaccine for kids ages 5 to 11

The endorsement was a critical step in getting some 28 million more kids in the U.S. protected against the virus as the delta variant spreads.

Read the full story at CNBC | Health and Science.